What to expect in the SUPERNUS PHARMACEUTICALS, INC. interview process

Based on publicly available sources, Supernus Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland. Operating in the healthcare sector, the company focuses on developing and commercializing products for central nervous system (CNS) diseases, with a diverse neuroscience portfolio including approved treatments for epilepsy, migraine, ADHD, and Parkinson’s disease symptoms.

Public records indicate that the company has a global workforce distributed across five countries, including the United States, India, Israel, Mexico, and the Philippines. Total headcount estimates fluctuate across reporting periods, ranging between approximately 665 and 925 employees, and the company has expanded its corporate footprint through acquisitions such as Adamas Pharma, Biscayne Pharma, and SAGE Therapeutics.

Regarding talent acquisition and hiring trends, data shows that Supernus has been actively hiring, recording an increase in active job postings. Leadership is headed by founder, president, and CEO Jack A. Khattar, who holds a strong approval rating of 92 out of 100 on company profile trackers, alongside a reported executive team that includes a Chief Financial Officer, Chief Scientific Officer, and Chief Technology Operations Officer. The organization operates in a competitive specialty pharmaceutical and biotechnology market alongside peers such as Alto Neuroscience, Newron Pharmaceuticals, and Seaport Therapeutics.